Gemcitabine for the Treatment of Advanced Biliary Tract Carcinomas: Evaluation of Two Different Dose Regimens

Publisher： Karger

E-ISSN： 2296-5262|22|6|498-501

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.6, 2000-01, pp. : 498-501

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy with Gemcitabine in Advanced Biliary Tract Carcinoma

By  

Reviews on Recent Clinical Trials, Vol. 3, Iss. 1, 2008-01 ,pp. : 70-78

Bentham Science Publishers

Access to resources Recommend Favorite

A Phase II Trial of Fixed-Dose Rate Gemcitabine plus Capecitabine in Metastatic/Advanced Biliary Tract Cancer Patients

By  

Oncology, Vol. 82, Iss. 2, 2012-02 ,pp. : 75-82

Karger

Access to resources Recommend Favorite

Renal Toxicity Associated with Weekly Cisplatin and Gemcitabine Combination Therapy for Treatment of Advanced Biliary Tract Cancer

By  

Oncology, Vol. 87, Iss. 1, 2014-06 ,pp. : 30-39

Karger

Access to resources Recommend Favorite

Treatment Efficacy/Safety and Prognostic Factors in Patients with Advanced Biliary Tract Cancer Receiving Gemcitabine Monotherapy: An Analysis of 100 Cases

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 39-45

Karger

Access to resources Recommend Favorite

Biweekly cisplatin and gemcitabine in patients with advanced biliary tract cancer

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1671-1675

John Wiley & Sons Inc

Access to resources Recommend Favorite